Screening of the Pandemic Response Box identifies anti-microsporidia compounds.

Microsporidia are fungal obligate intracellular pathogens, which infect most animals and cause microsporidiosis. Despite the serious threat that microsporidia pose to humans and agricultural animals, few drugs are available for the treatment and control of microsporidia. To identify novel inhibitors...

Full description

Bibliographic Details
Main Authors: Qingyuan Huang, Jie Chen, Guoqing Pan, Aaron W Reinke
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-12-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0011806
_version_ 1797366492301361152
author Qingyuan Huang
Jie Chen
Guoqing Pan
Aaron W Reinke
author_facet Qingyuan Huang
Jie Chen
Guoqing Pan
Aaron W Reinke
author_sort Qingyuan Huang
collection DOAJ
description Microsporidia are fungal obligate intracellular pathogens, which infect most animals and cause microsporidiosis. Despite the serious threat that microsporidia pose to humans and agricultural animals, few drugs are available for the treatment and control of microsporidia. To identify novel inhibitors, we took advantage of the model organism Caenorhabditis elegans infected with its natural microsporidian Nematocida parisii. We used this system to screen the Pandemic Response Box, a collection of 400 diverse compounds with known antimicrobial activity. After testing these compounds in a 96-well format at high (100 μM) and low (40 μM) concentrations, we identified four inhibitors that restored the ability of C. elegans to produce progeny in the presence of N. parisii. All four compounds reduced the pathogen load of both N. parisii and Pancytospora epiphaga, a C. elegans-infecting microsporidia related to human-infecting species. One of these compounds, a known inhibitor of a viral protease, MMV1006203, inhibited invasion and prevented the firing of spores. A bis-indole derivative, MMV1593539, decreased spore viability. An albendazole analog, MMV1782387, inhibited proliferation of N. parisii. We tested albendazole as well as 5 other analogs and observed that MMV1782387 was amongst the strongest inhibitors of N. parisii and displayed the least host toxicity. Our study further demonstrates the effectiveness of the C. elegans-N. parisii system for discovering microsporidia inhibitors and the compounds we identified provide potential scaffolds for anti-microsporidia drug development.
first_indexed 2024-03-08T17:04:56Z
format Article
id doaj.art-64eb2a97dce14a8c8cee3a485205e96c
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-03-08T17:04:56Z
publishDate 2023-12-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-64eb2a97dce14a8c8cee3a485205e96c2024-01-04T05:32:26ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352023-12-011712e001180610.1371/journal.pntd.0011806Screening of the Pandemic Response Box identifies anti-microsporidia compounds.Qingyuan HuangJie ChenGuoqing PanAaron W ReinkeMicrosporidia are fungal obligate intracellular pathogens, which infect most animals and cause microsporidiosis. Despite the serious threat that microsporidia pose to humans and agricultural animals, few drugs are available for the treatment and control of microsporidia. To identify novel inhibitors, we took advantage of the model organism Caenorhabditis elegans infected with its natural microsporidian Nematocida parisii. We used this system to screen the Pandemic Response Box, a collection of 400 diverse compounds with known antimicrobial activity. After testing these compounds in a 96-well format at high (100 μM) and low (40 μM) concentrations, we identified four inhibitors that restored the ability of C. elegans to produce progeny in the presence of N. parisii. All four compounds reduced the pathogen load of both N. parisii and Pancytospora epiphaga, a C. elegans-infecting microsporidia related to human-infecting species. One of these compounds, a known inhibitor of a viral protease, MMV1006203, inhibited invasion and prevented the firing of spores. A bis-indole derivative, MMV1593539, decreased spore viability. An albendazole analog, MMV1782387, inhibited proliferation of N. parisii. We tested albendazole as well as 5 other analogs and observed that MMV1782387 was amongst the strongest inhibitors of N. parisii and displayed the least host toxicity. Our study further demonstrates the effectiveness of the C. elegans-N. parisii system for discovering microsporidia inhibitors and the compounds we identified provide potential scaffolds for anti-microsporidia drug development.https://doi.org/10.1371/journal.pntd.0011806
spellingShingle Qingyuan Huang
Jie Chen
Guoqing Pan
Aaron W Reinke
Screening of the Pandemic Response Box identifies anti-microsporidia compounds.
PLoS Neglected Tropical Diseases
title Screening of the Pandemic Response Box identifies anti-microsporidia compounds.
title_full Screening of the Pandemic Response Box identifies anti-microsporidia compounds.
title_fullStr Screening of the Pandemic Response Box identifies anti-microsporidia compounds.
title_full_unstemmed Screening of the Pandemic Response Box identifies anti-microsporidia compounds.
title_short Screening of the Pandemic Response Box identifies anti-microsporidia compounds.
title_sort screening of the pandemic response box identifies anti microsporidia compounds
url https://doi.org/10.1371/journal.pntd.0011806
work_keys_str_mv AT qingyuanhuang screeningofthepandemicresponseboxidentifiesantimicrosporidiacompounds
AT jiechen screeningofthepandemicresponseboxidentifiesantimicrosporidiacompounds
AT guoqingpan screeningofthepandemicresponseboxidentifiesantimicrosporidiacompounds
AT aaronwreinke screeningofthepandemicresponseboxidentifiesantimicrosporidiacompounds